Pharmacoeconomics of opioid therapy for chronic non-malignant pain

By Marcus Dawn A  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite

Non-Analgesic Effects of Opioids: The Cognitive Effects of Opioids in Chronic Pain of Malignant and Non-Malignant Origin. An Update.

By  

Current Pharmaceutical Design, Vol. 18, Iss. 37, 2012-12 ,pp. : 6116-6122

Bentham Science Publishers

Access to resources Recommend Favorite

Pain management strategies can alleviate persistent non-malignant pain and minimise the risk of adverse events in the elderly

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 2, 2005-02 ,pp. : 15-19

Adis International

Access to resources Recommend Favorite

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Guide to Its Use in Chronic Non-Malignant Pain

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

CNS Drugs, Vol. 26, Iss. 4, 2012-04 ,pp. : 367-373

Adis International

Access to resources Recommend Favorite

Buprenorphine 5, 10 and 20 μg/h Transdermal Patch: A Review of its Use in the Management of Chronic Non-Malignant Pain

By Plosker Greg L.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2491-2509

Adis International

Access to resources Recommend Favorite